LKFT Short Volume
Galapagos N.V. Sponsored ADR (LKFT) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $1.83B, listed on NASDAQ, employing roughly 452 people, carrying a beta of 0.12 to the broader market. Galapagos NV is a biotechnology company, which engages in the identification and development of small molecule and antibody therapies. Led by Henry O. Gosebruch, public since 2005-05-05.
Short volume measures the number of shares sold short on a given day as reported by FINRA. Tracking short volume relative to total volume helps identify unusual bearish sentiment or short-squeeze potential.
- Latest Date
- 2026-06-01
- Short Volume
- 63.5K
- Total Volume
- 77.9K
- Short %
- 81.53%
- 30-Day Avg Short %
- 70.03%
Showing 16 days of FINRA short volume data for Galapagos N.V. Sponsored ADR.
Learn how short volume is reported and how to read the data →
Frequently asked LKFT short volume questions
- What is the daily LKFT short volume?
- As of Jun 1, 2026, Galapagos N.V. Sponsored ADR (LKFT) short volume is 63.5K shares against 77.9K total reported volume, or 81.53% short-side. Short volume measures shares sold short during the day; it is flow, not inventory.
- How is LKFT short volume reported?
- FINRA publishes the Daily Short Sale Volume File for trades reported to FINRA TRFs and the FINRA/Nasdaq ADF on a T+1 basis. The headline figure is the count of shares that printed at the short-sale or short-exempt tick across all reporting venues for the symbol; each exchange separately publishes its own daily short-sale data file.
- What does LKFT short volume tell options traders?
- Daily short-sale flow is one input that helps disambiguate dealer-hedging activity from directional bear flow when the chain shows fresh customer call inventory. It is not a clean MM-only proxy: the headline number mixes directional shorting, options-MM delta-hedging, ETF-creation arbitrage, and convertible-arb hedging. Cross-check against gamma-exposure and OI changes for a cleaner read.